EMBC - Embecta Corp.


9.71
-0.280   -2.884%

Share volume: 973,125
Last Updated: 03-03-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$9.99
-0.28
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
64%
Profitability 81%
Dept financing 43%
Liquidity 35%
Performance 60%
Company vs Stock growth
vs
Performance
5 Days
-5.36%
1 Month
-14.45%
3 Months
-16.87%
6 Months
-32.99%
1 Year
-22.94%
2 Year
-30.24%
Key data
Stock price
$9.71
P/E Ratio 
4.98
DAY RANGE
$9.59 - $9.94
EPS 
$1.61
52 WEEK RANGE
$9.20 - $15.55
52 WEEK CHANGE
-$25.31
MARKET CAP 
695.133 M
YIELD 
5.05%
SHARES OUTSTANDING 
59.220 M
DIVIDEND
$0.15
EX-DIVIDEND DATE
02-28-2025
NEXT EARNINGS DATE
05-08-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$764,006
AVERAGE 30 VOLUME 
$972,985
Company detail
CEO: Devdatt Kurdikar
Region: US
Website: embecta.com
Employees: 1,900
IPO year: 2022
Issue type:
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Embecta Corp. focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications. The company primarily sells its products to wholesalers and distributors in the United States and internationally.

Recent news